Bioventus settles securities class action for $15.25M; insurers to cover ~$6.5M

Bioventus Inc.

Settlement amount $15.25M plus interest, subject to court approval; all claims against Bioventus and defendants dismissed.
Insurers expected to pay approximately $6.5M of the settlement; no admission of liability or wrongdoing by any party.
Lawsuit alleged failure to disclose rebate practices, financial prospects, and internal controls; Exchange Act claims survived motion to dismiss.
Settlement reached July 15, 2024; payment due within 30 days after court preliminary approval and receipt of transfer info.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.